INDIVIOR PLC (INDV) Stock Fundamental Analysis
NASDAQ:INDV - Nasdaq - GB00BN4HT335 - Common Stock - Currency: USD
Taking everything into account, INDV scores 4 out of 10 in our fundamental rating. INDV was compared to 194 industry peers in the Pharmaceuticals industry. INDV has only an average score on both its financial health and profitability. INDV is valued quite cheap, but it does not seem to be growing. This makes INDV very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year INDV was profitable.
INDV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INDV reported negative net income in multiple years.
In multiple years INDV reported negative operating cash flow during the last 5 years.
1.2 Ratios
INDV has a better Return On Assets (-4.00%) than 77.32% of its industry peers.
Looking at the Return On Invested Capital, with a value of 111.88%, INDV belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for INDV is significantly above the industry average of 14.91%.
The 3 year average ROIC (43.06%) for INDV is below the current ROIC(111.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROIC | 111.88% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
In the last couple of years the Profit Margin of INDV has declined.
INDV has a better Operating Margin (25.44%) than 91.24% of its industry peers.
INDV's Operating Margin has been stable in the last couple of years.
INDV has a Gross Margin of 83.98%. This is amongst the best in the industry. INDV outperforms 89.18% of its industry peers.
INDV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
INDV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
INDV has less shares outstanding than it did 1 year ago.
The number of shares outstanding for INDV has been reduced compared to 5 years ago.
INDV has a worse debt/assets ratio than last year.
2.2 Solvency
INDV has an Altman-Z score of 3.19. This indicates that INDV is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of INDV (3.19) is better than 74.74% of its industry peers.
INDV has a debt to FCF ratio of 2.49. This is a good value and a sign of high solvency as INDV would need 2.49 years to pay back of all of its debts.
INDV has a Debt to FCF ratio of 2.49. This is amongst the best in the industry. INDV outperforms 92.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Altman-Z | 3.19 |
ROIC/WACC11.11
WACC10.07%
2.3 Liquidity
A Current Ratio of 0.88 indicates that INDV may have some problems paying its short term obligations.
INDV has a Current ratio of 0.88. This is amonst the worse of the industry: INDV underperforms 86.08% of its industry peers.
A Quick Ratio of 0.72 indicates that INDV may have some problems paying its short term obligations.
The Quick ratio of INDV (0.72) is worse than 85.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
INDV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.28%.
Measured over the past years, INDV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.07% on average per year.
The Revenue has been growing slightly by 4.34% in the past year.
The Revenue has been decreasing by -4.53% on average over the past years.
EPS 1Y (TTM)-24.28%
EPS 3Y-29.07%
EPS 5YN/A
EPS Q2Q%15.91%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y-4.53%
Revenue growth 5YN/A
Sales Q2Q%1%
3.2 Future
INDV is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -15.65% yearly.
Based on estimates for the next years, INDV will show a decrease in Revenue. The Revenue will decrease by -6.61% on average per year.
EPS Next Y8.11%
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
EPS Next 5Y-15.65%
Revenue Next Year3.53%
Revenue Next 2Y-2.92%
Revenue Next 3Y-9.06%
Revenue Next 5Y-6.61%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.03 indicates a correct valuation of INDV.
INDV's Price/Earnings ratio is rather cheap when compared to the industry. INDV is cheaper than 89.18% of the companies in the same industry.
When comparing the Price/Earnings ratio of INDV to the average of the S&P500 Index (26.82), we can say INDV is valued rather cheaply.
A Price/Forward Earnings ratio of 12.37 indicates a correct valuation of INDV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 81.96% of the companies listed in the same industry.
INDV is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.03 | ||
| Fwd PE | 12.37 |
4.2 Price Multiples
97.94% of the companies in the same industry are more expensive than INDV, based on the Enterprise Value to EBITDA ratio.
84.02% of the companies in the same industry are more expensive than INDV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.9 | ||
| EV/EBITDA | 4.7 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
INDV has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as INDV's earnings are expected to decrease with -10.28% in the coming years.
PEG (NY)1.48
PEG (5Y)N/A
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
5. Dividend
5.1 Amount
No dividends for INDV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
21.05
+0.85 (+4.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners86.46%
Inst Owner Change-0.21%
Ins Owners3.78%
Ins Owner ChangeN/A
Market Cap2.63B
Analysts82.5
Price Target14.88 (-29.31%)
Short Float %7.23%
Short Ratio4.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.73%
PT rev (3m)-3.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.03 | ||
| Fwd PE | 12.37 | ||
| P/S | 1.27 | ||
| P/FCF | 19.9 | ||
| P/OCF | 15.82 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.7 |
EPS(TTM)1.75
EY8.31%
EPS(NY)1.7
Fwd EY8.08%
FCF(TTM)1.06
FCFY5.03%
OCF(TTM)1.33
OCFY6.32%
SpS16.51
BVpS-2.28
TBVpS-2.34
PEG (NY)1.48
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROCE | 141.62% | ||
| ROIC | 111.88% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% | ||
| FCFM | 6.41% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score5
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 136% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 3.19 |
F-Score5
WACC10.07%
ROIC/WACC11.11
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.28%
EPS 3Y-29.07%
EPS 5YN/A
EPS Q2Q%15.91%
EPS Next Y8.11%
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
EPS Next 5Y-15.65%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y-4.53%
Revenue growth 5YN/A
Sales Q2Q%1%
Revenue Next Year3.53%
Revenue Next 2Y-2.92%
Revenue Next 3Y-9.06%
Revenue Next 5Y-6.61%
EBIT growth 1Y103.89%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year13.79%
EBIT Next 3Y10.08%
EBIT Next 5Y12.03%
FCF growth 1Y473.91%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y374.29%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%